This inventor holds 3 USPTO granted patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2012-2019.
Company Filing History:
Years Active: 2012-2019
Title: Lori S Tillmans: Innovator in Cancer Research
Introduction
Lori S Tillmans is a prominent inventor based in Stanton, MN (US). She has made significant contributions to the field of cancer research, particularly in assessing prostate cancer outcomes. With a total of 3 patents to her name, her work has the potential to impact the lives of many patients.
Latest Patents
Among her latest patents is a groundbreaking document titled "Predicting Cancer Outcome." This patent provides methods and materials related to assessing prostate cancer in mammals. It includes nucleic acids and polypeptides that can be analyzed to determine whether a male mammal with prostate cancer is susceptible to a good or poor outcome. This innovative approach aims to enhance the understanding of cancer prognosis and improve patient care.
Career Highlights
Lori S Tillmans is affiliated with the Mayo Foundation for Medical Education and Research, where she continues to advance her research in cancer outcomes. Her dedication to innovation in medical science has positioned her as a key figure in her field.
Collaborations
She has collaborated with notable colleagues, including John C Cheville and Farhad Kosari, to further her research initiatives. These partnerships have enriched her work and contributed to the development of effective cancer assessment methods.
Conclusion
Lori S Tillmans exemplifies the spirit of innovation in cancer research. Her contributions through patents and collaborations are paving the way for advancements in understanding prostate cancer outcomes. Her work is a testament to the impact that dedicated inventors can have on healthcare and patient outcomes.